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Dobutamine stress echocardiography: 
Prevalence of a nonischemic response in a 
low-risk population 
The problems of population referral bias in the calculation of specificity in diagnostic testing for 
coronary artery disease have been previously described. Previous studies investigating the 
sensitivity and specificity of dobutamine stress echocardiography (DSE) have been subject to 
pretest and posttest referral biases, largely as a result of the requirement for coronary 
arteriography. This study determines the normalcy rate for DSE by examining a population at 
statistically low risk for coronary artery disease. The probability of significant coronary artery 
disease was determined for 828 consecutive patients referred for DSE at the University of 
Michigan, and groups were identified with <iO% and <5% probability of disease. Four of 72 
patients (5.6%) with a normal baseline echocardiogram and a probability of coronary artery 
disease of <lo%, and three of 38 (7.9%) with a probability of <5% were found to have an 
abnormal DSE, yielding normalcy rates of 94.4% and 92.1%, respectively. The area of 
abnormality involved the posterior circulation in three of four patients (75%). This study 
demonstrates that DSE has a normalcy rate of 92% to 94% and is an accurate test for excluding 
the presence of significant coronary artery disease. (AM HEART J 1993;125:1257.) 
David S. Bach, MD, Anne Hepner, MD, Pamela A. Marcovitz, MD, and 
William F. Armstrong, MD Ann. Arbor, Mich. 
Dobutamine stress echocardiography (DSE) is an 
accurate and feasible method for the noninvasive de- 
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tection of coronary artery disease.l-lo Using selective 
coronary angiography as a measure of accuracy, the 
sensitivity of DSE for the detection of coronary 
artery disease has been high, ranging from 68% to 
97 % .3-10 The specificity of DSE, however, has been 
more variable, ranging from as high as 1OO%4 to as 
low as 45 % .3 Several factors may be responsible for 
the low test specificity in these studies. In addition to 
the possibility of error in test interpretation, pretest 
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and posttest selection biases may have been intro- 
duced in the selection of study populations. These 
biases exist to a large extent because of the require- 
ment of invasive coronary arteriography for the doc- 
umentation of coronary artery disease, and have been 
noted previously to influence the specificity of exam - 
inations in “unselected” patient populations.” 
Several studies have addressed the problems ot 
specificity calculation for diagnostic testing in the 
exclusion of coronary artery disease.l”-l” Pretest se- 
lection bias occurs16, i7 when the study population is 
made up of patients with a high pretest probability 
of disease. In the case of DSE, factors contributing to 
this include the conduction of studies in the setting 
of university-based tertiary referral hospitals where 
the incidence and severity of coronary artery disease 
is greater than in the general population, and the in- 
clusion of patients in the study population who 
already have the established diagnosis of coronary 
artery disease. This includes patients undergoing 
testing following myocardial infarction, and patients 
referred for DSE following cardiac catheterization 
for the assessment of the significance of already de- 
tected coronary artery disease. 
Inclusion of patients with nonischemic cardiac 
disease may also contribute to pretest referral bias. 
These patients often have wall motion abnormalities 
at rest and thus are more likely to have false positive 
DSEs than are patients without underlying cardiac 
diseases.3 Additionally, they are more likely to un- 
dergo diagnostic cardiac catheterization. As such, the 
pool of patients undergoing cardiac catheterization 
includes a disproportionate number of patients pre- 
selected to have a false positive test. 
Posttest referral bias may also contribute to a poor 
specificity for DSE. As the test has gained clinical use 
since its introduction, patients are more likely to un- 
dergo subsequent diagnostic cardiac catheterization 
following a positive DSE than following a negative 
test. As such, most patients with a false positive test 
will undergo coronary arteriography, while the ma- 
jority of patients with negative results will not. As has 
been previously described,‘(j this will result in a de- 
cline in the measured test specificity. 
These referral biases may be responsible for the 
relatively poor test specificity of DSE in previous 
studies. Given these constraints on population selec- 
tion, alternative means must be used for determining 
the ability of the test to accurately predict the 
absence of disease. Precedent exists in clinical studies 
for the use of normalcy, the occurrence of a negative 
test in a population at statistically low risk for 
disease,ls-19 to decrease the selection bias accompa- 
nying the requirement for invasive coronary angiog- 
raphy. This study was designed to assess the nor- 
malcy rate of DSE by reviewing t.ests performed in 
patients who are at statistically low risk of having 
significant coronary artery disease. 
METHODS 
Study population. Clinical characteristics and DSE re- 
sults were retrospectively reviewed for all patients referred 
for DSE at the University of Michigan Medical Center be- 
tween January 1990 and September 1991. The probability 
of significant coronary artery disease was established using 
a previously described nomogram.“s Probability was based 
on the age and sex of the patient, a history of diabetes, hy- 
perlipidemia or tobacco use, previous history of myocardial 
infarction or abnormalities on electrocardiography, and a 
history of typical or atypical chest pain. Based on these 
criteria, patients were identified with a probability of sig- 
nificant coronary artery disease of less than 10”F8. Addi- 
tionally, subsets of patients with a probability of coronary 
artery disease of less than 5’, and those with a probability 
of disease between 5”,’ and lO”(; were identified. 
Dobutamine echocardiography. Dobutamine stress 
echocardiograms were performed using a previously re- 
ported protocol. lo The protocol was undertaken after 
approval of the University of Michigan Human Subjects 
Committee, and informed consent was obtained from each 
patient. Dobutamine was administered as a continuous in- 
travenous infusion in S-minute stages at doses of 5,10,20, 
and 30 pg/kg/min. Heart rate was continuously monitored. 
Images were obtained in standard parasternal long- and 
short-axis views, and in apical four-chamber and two 
chamber views. Two-dimensional echocardiograms were 
recorded at baseline and at. each stage of dobutamine infu- 
sion. Blood pressure and 12-lead electrocardiography were 
obtained at baseline, at the completion of each stage, and 
at 5 minutes following infusion termination. Indications for 
discontinuation of the protocol included the development 
of significant chest pain or a new wall motion abnormality 
on echocardiography. Echocardiographic images were dig- 
itized at baseline, during 5 ~glkglmin infusion, at peak 
dobutamine infusion, and at 5minutes of recovery. 
All analyses were completed by a highly experienced ob- 
server (WFA). Echocardiograms were interpreted prospec- 
tively, intermixed with other daily stress and dobutamine 
stress studies, and nomogram-derived probabilities of cor- 
onary artery disease were subsequently calculated. AS such, 
the interpreter was blinded to the nomogram-derived 
probability of coronary artery disease at the time of inter- 
pretation of the echocardiogram. 
A normal response to dobutamine infusion is hyperdy- 
namic motion in all visualized areas of the left ventricle. An 
abnormal test for the detection of coronary artery disease 
was defined as the presence of a resting wall motion abnor- 
mality, or the induction of a new or worsened wall motion 
abnormality during dobutamine infusion. The latter was 
considered as evidence of inducible ischemia. 
Catheterization. Cardiac catheterization was performed 
between 0 and 149 (mean 47.5 +- 61.3, median 8) days of the 
DSE in nine patients in whom there was a clinical indica- 
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Table I. Patient demographics 
Age Age Age Atypical ST segment/ 
CAD prob- Population range mean median NO. No. chest Diabetes Hypercholes- Tobacco T wave 
ability size (n) (yr) (yr) Cvr) mule female pain mellitus terolemia use abnormalities 
<lo”;. 75 19-65 41.8 41 20 55 37 4 1 4 3 
<59; 39 19-52 37.5 37 9 30 13 1 1 1 1 
CM, Coronary artery disease. 




All subjects Normal baseline echocardiogram 
Population Abnormal Population Abnormal 
site (n) DSE size (n) DSE Normalcy 
<10x 75 5 72 4 5.6 94 I’; 
<590 39 4* 38 3t 7.9 92 0; 
5 g, - 10 4; 36 1* 34 Ii 2.9 97 “b 
Abbreviations as in Table I. 
*p = 0.36. 
tp = 0.62. 
tion for the procedure. The angiograms were reviewed and 
interpreted by an experienced observer. Significant ob- 
structive coronary artery disease was felt to be present if 
there was a 50% or greater stenosis in any of the major 
epicardial coronary arteries. 
Statistical analysis. The incidence a of positive DSE for 
the groups with probability of coronary artery disease of 
less than 5 % and for those with probability of disease of 5 % 
to 10% were compared using a Fisher exact test (two-tail). 
The Fisher exact test was also used for comparison of the 
incidence of a positive DSE among male and female 
patients. A significant difference was defined as p < 0.05. 
RESULTS 
Patient demographics. Clinical characteristics of 
828 patients referred for DSE were reviewed. Of 
these, 75 patients were identified with a probability 
of significant coronary artery disease of less than 
10 %. This group included 20 (27%) men and 55 
(73 % ) women. The age range was 19 to 65 years, with 
a mean of 41.8 years. The age range of the male pa- 
tients was 19 to 45 (mean 33.1 -+ 5.1) years, and that 
of the female patients was 26 to 65 (mean 44.8 5 9.6) 
years. Clinical characteristics are summarized in Ta- 
ble I. 
Indications for referral for DSE included evalua- 
tion of chest pain in 30 patients, preoperative cardiac 
risk assessment in 23 (including eight patients under- 
going evaluation for lung transplantation), evalua- 
tion of palpitations or arrhythmia in seven, evalua- 
tion of dyspnea or conduction abnormality in two 
each, evaluation of syncope or dilated cardiomyop- 
athy in one patient each, and completion of other 
protocols in six patients. No indication was available 
in three patients. 
Thirty-seven patients (49%) had a history of 
atypical chest pain. Only 11 patients (15% ) had one 
or more risk factors that increased the probability of 
coronary artery disease, using the nomogram of Pryor 
et a1.20 These risk factors included diabetes in four 
patients, hyperlipidemia in one patient, a history of 
tobacco use in four patients, and baseline ST segment 
or T wave abnormalities on resting electrocardio- 
graphy in three patients. A single patient had two risk 
factors; a 30-year-old man with diabetes and resting 
ST segment abnormalities on electrocardiography, 
who was referred for DSE as part of a preoperative 
cardiac evaluation. No patients had a history of pre- 
vious myocardial infarction or electrocardiographic 
evidence of a previous myocardial infarction. Thirty- 
nine patients had a probability of coronary artery 
disease of less than 5%. 
Dobutamine stress echocardiography. The DSE pro- 
tocol was completed in all 75 patients. No patients 
developed chest pain during the infusion. Among all 
patients with a probability of coronary artery disease 
of less than 10” ,*, DSE was positive for ischemia in 
five patients (6.7% ), including four (80% ) women. 
These data are summarized in Table II. The inci- 
dence was 7.2 % (4 of 55) in women and 5.0% (1 of 20) 
in men (p = 1.0). The age range for these patients was 
31 to 52 (mean 41.4 * 8.8) years. One patient, whose 
status was evaluated 4 days after pericardiocentesis, 
had a resting inferior wall motion abnormality and a 
small residual pericardial effusion. None of the other 
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Table III. Abnormal dobutamine stress echocardiograms (DSEs) 
CAD 
Age Pr0bddit?/ DSE risk Baseline 
(y-J Sex of CAD indication factors echocardiogram 
.31 M <5(,, Atyp CP None Normal 
34 F <5’6 Preop Tobacco Normal 
43 F <jr; Atyp CP None Normal 
47 F <5’, Preop ST abn Inferior 
WMA 


























Atyp CP, Atypical chest pain; Preop, preoperative assessment; STabn, ST segment abnormalities: WMA, wall motion abnormality; N/A. not available; other 
abbreviations as in Table I. 
*Residual pericardial effusion 4 days following pericardiocentesis 
four patients had a resting wall motion abnormality. 
The area of induced wall motion abnormality was 
anterior in one patient, inferior in three, and infero- 
posterior in one. Three of these five patients under- 
went coronary arteriography. None of these three 
patients, nor any of the other six patients with neg- 
ative DSEs undergoing coronary arteriography had 
evidence of significant coronary artery disease. Four 
of 39 patients (10.2 % ) with a less than 5 % probabil- 
ity of coronary artery disease, and one of 36 patients 
(2.8% ) with a probability of coronary artery disease 
between 5% and 10% had an abnormal DSE (Table 
II). Induced wall motion abnormalities involved the 
inferior wall in three and the anterior wall in one pa- 
tient. The clinical and echocardiographic character- 
istics of these patients are summarized in Table III. 
In addition to the patient with residual pericardial 
effusion and a baseline inferior wall motion abnor- 
mality 4 days following pericardiocentesis, two pa- 
tients in the group had a severe dilated cardiomyop- 
athy. Excluding patients with underlying cardiomy- 
opathy, pericardial or valvular disease, 3 of 38patients 
(7.9 % ) with a probability of coronary artery disease 
of less than 5 % , and 1 of 34 patients (2.9 % ) with a 
probability of disease between 5% and 10% had a 
DSE positive for ischemia. There was no statistically 
significant difference between these groups with re- 
spect to the incidence of an abnormal DSE (p = 0.62). 
In the group of 72 patients with a probability of cor- 
onary artery disease of less than 10% and a normal 
baseline echocardiogram, four patients (5.6 % ) had 
an abnormal DSE. 
DISCUSSION 
Previous studies assessing the accuracy of DSE for 
the detection of coronary artery disease have been 
performed using patient populations subject to pre- 
test and posttest referral bias. Study populations 
have been drawn from university-based settings and 
have included patients following acute myocardial 
infarction, patients referred from the cardiac cathe- 
terization laboratory, and patients referred for car- 
diac catheterization based on the results of the DSE. 
In each case, either pretest selection bias existed such 
that the population under study had a greater prev- 
alence of coronary artery disease than would be ex- 
pected in a general population referred to the echo- 
cardiography laboratory, or posttest referral bias ex- 
isted as a result of referral for subsequent cardiac 
catheterization based on the results of the echocar- 
diogram. Because of these selection biases, the study 
populations may have contained fewer than expected 
numbers of patients without coronary artery disease, 
and determination of the test specificity may have 
been subsequently impaired. To circumvent these 
selection biases, this study was designed to assess the 
ability of DSE to exclude the presence of significant 
coronary artery disease in a population at very low 
risk for disease. As risk for coronary artery disease 
was used for selection criteria, none of the biases in 
patient selection that accompany studies requiring 
cardiac catheterization as a comparative standard 
were operative. Clinical characteristics were reviewed 
for patients referred for DSE, and patients with a less 
than 10% or a less than 5 % probability of having 
significant coronary artery disease were identified 
using a previously described nomogram for the pre- 
diction of coronary artery disease probability in an 
individual. Particularly in the lowest probability 
group, the patient population was skewed to contain 
a predominance of women and patients under 40 to 
50 years of age, as well as patients without significant 
independent risk factors for coronary artery disease. 
The patients were otherwise representative of pa- 
tients referred for DSE. 
The incidence of an abnormal and presumed false 
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positive DSE was 6.7 % (5 of 75 patients). Excluding 
patients who had baseline cardiomyopathy, pericar- 
dial or valvular disease, the incidence was 5.6 % . The 
incidence was 7.9% among those with a probability 
of coronary artery disease of less than 5 % , and 5.6 % 
in the group of patients with a probability of less than 
10 % , yielding normalcy rates for DSE of 92 % and 
94 % , respectively. A higher incidence of an abnormal 
DSE was noted in the group with a lower predicted 
coronary disease probability, but the difference is not 
statistically significant and is most likely a function 
of the relatively small size of the two groups. The 
normalcy rate of 92 % to 94 % is in close agreement 
with the specificity of 91 “;o for DSE in patients with 
normal baseline echocardiograms previously reported 
from our laboratory. lo This population of patients 
with normal resting function excludes many patients 
with nonischemic cardiac diseases, and results in 
fewer false positive tests. 
The majority of false positive DSEs in this study 
were in the posterior circulation, with only one 
patient developing an inducible abnormality in the 
anterior circulation. This is consistent with findings 
in previous studies that inducible abnormalities in 
the posterior circulation are more likely to represent 
false positive DSEs than do anterior circulation ab- 
norma1ities.l’ The mechanism underlying this obser- 
vation is uncertain, but many represent either ob- 
server error because of suboptimal visualization in 
this area, or wall motion abnormalities related to 
nonischemic but as yet unidentified mechanisms. 
Conclusions. DSE has been previously demon- 
strated to be highly sensitive for the detection and 
localization of coronary artery disease. Test specific- 
ities ranging from 100% to 45% in previous studies 
may have been compromised by potential pretest and 
posttest referral biases in the populations studied. 
This study demonstrates that DSE has a normalcy 
rate of 92 % to 94 % in patients at low likelihood of 
having disease, with false positive tests predomi- 
nantly involving the posterior circulation. DSE is a 
reasonable test for excluding the presence of signif- 
icant coronary artery disease in nonselected patient 
populations. 
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